März 2010 - IOZK

Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines

2010-03-30/in Hepatocellular Carcinoma, International Publications /von 2010-03-30 / Hepatol. Res. 2010 May;40(5):505-13

Differential effects of Paclitaxel on dendritic cell function

2010-03-19/in Dendritic Cells, International Publications /von 2010-03-19 / BMC Immunol. 2010 Mar;11:14

Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells

2010-03-18/in Dendritic Cells, International Publications /von 2010-03-18 / Ann. Hematol. 2010 Aug;89(8):795-801

Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma

2010-03-17/in Cervical Cancer, Hyperthermia, International Publications /von 2010-03-17 / Cochrane Database Syst Rev 2010 Mar;(3):CD006377

Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer

2010-03-12/in Dendritic Cells, International Publications, NSCLC /von 2010-03-12 / Lung Cancer 2010 Nov;70(2):188-94

Building on dendritic cell subsets to improve cancer vaccines

2010-03-11/in Dendritic Cells, International Publications /von 2010-03-11 / Curr. Opin. Immunol. 2010 Apr;22(2):258-63

Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma

2010-03-10/in Hepatocellular Carcinoma, International Publications /von 2010-03-10 / J. Cancer Res. Clin. Oncol. 2010 Nov;136(11):1745-54

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

2010-03-05/in Dendritic Cells, International Publications /von 2010-03-05 / Cancer Immunol. Immunother. 2010 Oct;59(10):1573-82

New perspectives in cancer virotherapy: bringing the immune system into play

2010-03-01/in International Publications, Newcastle Disease Virus /von 2010-03-01 / Immunotherapy 2010 Mar;2(2):185-99

Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia

2010-03-01/in Hyperthermia, International Publications /von 2010-03-01 / Immunol. Res. 2010 Mar;46(1-3):137-54